Fujian Shengdi Pharmaceutical Co., Ltd. clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.

1. Notable

   HRS-7249 · Hypertriglyceridemia

   Recruitment opened

   Also in this update: Start date changed from estimate of Sep 30, 2026 to Sep 11, 2026

   Fujian Shengdi Pharmaceutical Co., Ltd.·Phase 2· NCT07799688· Registry history of NCT07799688 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

2. Notable

   HRS-4139 in Healthy Participants

   Recruitment opened

   Fujian Shengdi Pharmaceutical Co., Ltd.·Phase 1· NCT07802964· Registry history of NCT07802964 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.